Novel therapeutic bispecific antibodies for B-cell lymphoma
“Our results indicate that IgM-dependent bispecific antibodies are potent therapeutic agents for B-cell malignancies.”Credit: 2024 Ohashi et al. “Our results...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
“Our results indicate that IgM-dependent bispecific antibodies are potent therapeutic agents for B-cell malignancies.”Credit: 2024 Ohashi et al. “Our results...
New research from the University of Pittsburgh explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive...
Osaka, Japan – Antisense oligonucleotides (ASOs) are next-generation drugs that can treat disease by blocking the transfer of harmful messages...
**Embargo: 23.30 / 19.30 , Monday 15 April 2024** Credit: The Lancet **Embargo: 23.30 / 19.30 , Monday 15 April 2024** ...
ROCHESTER, Minnesota — Mayo Clinic researchers recently invented a new class of artificial intelligence (AI) algorithms called hypothesis-driven AI that are...
Drug-loaded 3D printed films could change cancer treatments forever as world first research from the University of South Australia shows...
MIAMI, FLORIDA (April 12, 2024) – An advisory committee at the U.S. Food and Drug Administration voted 12-0 today in...
Neli Ulrich, PhD, MS, chief scientific officer and executive director of the Comprehensive Cancer Center atHuntsman Cancer Institute at the University of...
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) and the NCCN Foundation® today announced five winners for the...
New research from the University of Oklahoma reveals a previously unknown chain of events sparking the development of cancer cachexia,...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine